Commercial League - Global Pharma Centre JSC
AS203312 is Commercial League - Global Pharma Centre JSC (comleague.com). It announces 1,024 IPv4 addresses in 4 prefixes, and 1 IPv6 prefixes.
Bulgaria· RIPE· allocated 2016-02-16· business
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- Bulgaria1,024 · 100.00%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- CL-AS
- name
- Commercial League - Global Pharma Centre JSC
- org
- ORG-CA1641-RIPE
- org name
- Commercial League - Global Pharma Centre JSC
- org address
- Bulgaria, Sofia 1172, 1 G. M. Dimitrov Blvd.
- org country
- BG
- country
- BG
- source
- ripe
- status
- ASSIGNED
- created
- 2016-02-16
- updated
- 2024-10-24
- maintainer
- RIPE-NCC-END-MNT|SPNET-MNT
- abuse name
- abuse-c
- abuse email
- n.zaynelov.hq@comleague.com
- abuse kind
- role
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- None here
- proxyseller0.10%
- None here
- None here
- None here
- None here
- Hosting IP25625.00%
- None here
- Carrier IP768A1 BG75.00%
- None here
- SSH IP100.98%
- 0.39%
- 0.49%
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 78.83.211.0/24 | Bulgaria | valid | 16 | 2026-10-02 |
| 82.103.79.0/24 | Bulgaria | valid | 16 | 2026-10-02 |
| 151.251.61.0/24 | Bulgaria | valid | 16 | 2026-10-02 |
| 195.34.122.0/24 | Bulgaria | valid | 16 | 2026-10-02 |
IPv6 prefixes
Every IPv6 prefix BGP Route saw it announce.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 2001:678:9e0::/48 | Bulgaria | valid | 19 | 2026-10-02 |
Test the real build first.
An evaluation license puts a full current build in your hands — every row, every column, no sampling — so you can measure it against your own traffic before anyone talks about terms.